Antitumor Activity of Trastuzumab Deruxtecan in Pediatric Solid Tumors with Variable HER2 Expression.
Saved in:
| Title: | Antitumor Activity of Trastuzumab Deruxtecan in Pediatric Solid Tumors with Variable HER2 Expression. |
|---|---|
| Authors: | Burke CM; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Feinberg TY; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Brosius S; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Bhanot UK; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Jain M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Linkov I; Pathology Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York., Siddiquee A; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Guillan K; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Ibáñez G; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Ndengu AA; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Calder P; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Rosales N; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Coutinho DF; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Long MM; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Fishkin R; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Thyparambil S; mProbe Inc., Rockville, Maryland., Glade Bender JL; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Reed DR; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., You D; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Ortiz MV; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Slotkin EK; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Kung AL; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Dela Cruz FS; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York. |
| Source: | Molecular cancer therapeutics [Mol Cancer Ther] 2026 Jan 02; Vol. 25 (1), pp. 156-167. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
